background: Obstetric haemorrhages have been reported to be increased after assisted reproduction technologies (ART) but the mechanisms involved are unclear.
Introduction
Obstetric haemorrhage and primary post-partum haemorrhage (PPH) are important causes of maternal mortality worldwide (World Health Organisation, 2007) . Antepartum haemorrhage (APH), placenta praevia (PP) and placental abruption (PA) are major obstetric complications in all countries. Increased frequencies of these complications with births after assisted reproduction technology (ART) have been reported by several groups (Daniel et al., 2000; Perri et al., 2001; Smithers et al., 2003; Jackson et al., 2004; Kallen et al., 2005b; Shevell et al., 2005; Romundstad et al., 2006; Schieve et al., 2007) . Although increased multiple births after ART were an important factor increasing obstetric haemorrhages, PP and PA are also known to be more frequent with singleton deliveries after ART than after natural conceptions in matched controls but the mechanisms involved are not clear and deserve further study (Schieve et al., 2007) .
We have previously reported a high frequency of APH and PP in IVF twin pregnancies (Smithers et al., 2003) . We speculated this was a consequence of embryo transfer through the vagina and cervix, compared with in-vivo conception and implantation via the uterine tube. More recently, Romundstad et al. (2006) confirmed an increased risk of PP [adjusted OR 5.6, 95% confidence interval (CI) 4.4 -7.0] in 5581 singleton ART births. They also compared results of two births in the same woman who had both an ART and a natural conception and found that the risk of PP was also higher (OR 2.9) in the ART pregnancy. These authors suggested the higher risk of PP was largely attributed to factors related to the ART and that APH and PP may occur as a consequence of embryo transfer through the vagina and cervix.
Studying factors affecting obstetric haemorrhage after ART is important because ART accounts for 3-5% of all births in developed countries and is increasing in use. Understanding the mechanisms might lead to prevention not only of these haemorrhages in ART pregnancies but also those in the general community. PPH has not previously been reported in detail in ART patients (Kallen et al., 2005b ), yet PPH is a leading cause of maternal death. Studying singleton births is appropriate with the general move to elective single embryo transfer to minimize the multiple pregnancy rate with ART.
Here we report a multi-centre study of obstetric haemorrhage and PPH in singleton births of patients who conceived with IVF or ICSI and comparison groups from the general community, women who conceived with gamete intrafallopian transfer (GIFT), and infertile women who became pregnant without ART. Our strategy was as follows: firstly, to replicate the findings that the risks of these haemorrhages are greater after IVF/ICSI than in the general population after adjusting for confounding factors; secondly, to compare the frequencies of the haemorrhages after IVF/ICSI and GIFT to assess the effect of manipulation and culture of the embryos in the embryology laboratory as this does not occur with GIFT; thirdly, to compare the frequencies of the haemorrhages after IVF/ICSI and non-ART conception in infertile women to examine the effect of infertility; and fourthly, to examine factors within the IVF/ICSI group that might be related to haemorrhages.
Materials and Methods
The project was approved by each Human Research and Ethics committee of the hospitals involved and the Victorian Department of Human Services.
Data sources

Art clinic databases
The infertility clinics are required to keep comprehensive records of all procedures that result in birth by Victorian State regulations and for reporting to the Fertility Society of Australia's Reproductive Technology Accreditation Committee and all patients sign consent forms acknowledging this. The databases include information on clinical features, diagnosis, treatments and the embryos. Additional information about investigations and lifestyle factors was added from the patients' records.
Victorian birth data
In the Victorian Department of Human Services, the Perinatal Data Collection Unit (PDCU) oversees mandatory registration of all births of 20 weeks gestation and over. There were approximately 862 000 singleton births in the study period (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) . Miscarriages and terminations of pregnancy at ,20 weeks gestation are not registered as births in Victoria unless a birth defect is recorded. Data on the existing maternal medical conditions, previous pregnancies, gestation at birth, maternal complications of pregnancy and mode of delivery are provided on forms by midwives involved with the births and entered on computer centrally. Over 99.6% of all births in Victoria were reported to the PDCU in 1996 (Riley and Griffin, 1997) .
Subjects
The ART data relate to women treated in the state of Victoria by any of three infertility services: Melbourne IVF, Monash IVF and the Melbourne Assisted Conception Centre (MACC) between January 1991 and December 2004. Only the subjects' first singleton birth during the study period were included. This is a retrospective cohort study using record linkage to obtain the information on obstetric haemorrhages in infertile women conceiving after IVF or ICSI and three comparison groups: women conceiving in the general community and infertile women conceiving by GIFT or without ART.
In vitro fertilization/intracytoplasmic sperm injection
For this group, oocytes were collected by transvaginal ultrasound guided oocyte collections under neurolept or general anaesthesia. ICSI was introduced in 1993. Treatment of male infertility was attempted with standard IVF before the introduction of ICSI. Stimulation regimens involved clomiphene, human menopausal gonadotrophin and human chorionic gonadotrophin up to 1993. The oral contraceptive pill was used increasingly after 1995 to regulate the starting time of gonadotrophin treatment. Long down-regulation with gonadotrophin releasing hormone agonists was used after 2001. Recombinant FSH was used after 1994. Gonadotrophin releasing hormone antagonists were used in increasing numbers of patients after 2000.
Culture media changed from human tubal fluid to multi-stage media in 2000. The protein supplement was human serum albumin until 2000 and highly purified albumin thereafter. Embryo cryopreservation involved propanediol with embryo freezing on day 2, 3 or 5. Cryopreserved embryos were thawed and transferred on the same day as their age after ovulation in natural or artificial cycles until 1996. After September 1997, all cryopreserved embryos were thawed the day before transfer and cultured overnight so they would be on average 18 h more advanced than embryos transferred fresh. Frozen-thawed ET (FET) was usually performed in natural menstrual cycles but women with oligomenorrhoea or amenorrhoea had artificial cycles induced with cyclical estradiol and progesterone treatment. Some other patients had luteal phase support with hCG or progesterone. During the time of the study relatively low numbers of embryos were transferred and the multiple pregnancy rate was ,20%. Embryo cryopreservation was common and approximately one third of the singleton births were from FET.
National health funding of ART covered about half of the patient's costs. Patients without private health insurance or their own specialist gynaecologist were classified as semiprivate and this is an indicator of socioeconomic status.
General population
For each IVF/ICSI subject, three records of singleton births were randomly selected from the PDCU data matching on year of maternal age and year of birth of the baby to balance the exposed and unexposed groups on maternal age and possible temporal changes in ascertainment of the obstetric haemorrhages.
Gamete intrafallopian transfer
The results of singleton births from GIFT were analysed to determine if the in-vitro fertilization and embryology laboratory procedures contributed to the outcome, as these do not occur with GIFT. GIFT was performed under general anaesthesia and involved laparoscopic placement of the oocytes and spermatozoa into the ampulla of a uterine tube via the fimbrial end of the tube. Most of the GIFT was performed between 1990 and 1998. Except at one centre (MACC), extra oocytes not transferred were inseminated and embryos resulting were cryopreserved.
Non-ART
Infertile women who conceived without ART (non-ART group) were analysed to determine the contribution of infertility itself to the outcomes. The women were classified as 'infertile' because they were seen in the Melbourne or Monash clinics between 1991 and 2000 but were known not to have given birth after IVF, ICSI, GIFT or donor insemination at the three Melbourne clinics. They were found in the Victorian PDCU birth data to have given birth to a singleton baby within 5 years of registration at the clinics. They may or may not have had ART treatment but any ART treatments did not result in a birth after 20 or more weeks gestation. Some patients may have been treated by ovulation induction or artificial insemination but most would have naturally conceived. The possibility that they had conceived by ART at other clinics interstate or overseas was checked by inspection of the patient records. The three Melbourne clinics performed most of the ART procedures in the State during the time of the study (.98% of clinical pregnancies, www.ita.org.au) and reproductive tourism was infrequent.
Exclusions
Donor oocyte and embryo recipients (n ¼ 339) were excluded. By chance, some women in the IVF/ICSI, GIFT and non-ART groups who also had naturally conceived children were matched with other IVF/ICSI group subjects. Similarly some women with more than one birth were in the general population group. All these second and subsequent pregnancies in the study groups were excluded so that each woman was only analysed once thus avoiding correlations between outcomes that might otherwise occur.
Primary outcome: haemorrhages
The obstetric haemorrhages were defined using the Victorian PDCU electronic user manual. APH was coded when bleeding of 15 ml or more occurred from the birth canal after 20 weeks gestation and before the birth of the baby. This overarching category includes PP, PA and APH for 'other reasons'. PP was coded where the placenta was located over or very close to the cervical os as verified by independent ultrasound examination and confirmed at birth. APH may or may not have occurred. The standardized form sent to the PDCU does not differentiate between marginal PP (grade I) from more major PP (grade II -III) to grade IV PP which cover the internal cervical os. PA was coded where there was premature separation of the placenta. There was evidence of retroplacental bleeding and the amount of blood lost was always moderate or severe whether out of the vagina or internally. PPH was coded when there was blood loss greater than 500 ml within 24 h of vaginal delivery or childbirth or greater than 750 ml after Caesarean section. The PDCU definitions are consistent with the International Classification of Diseases (ICD10) coding system. In this study, six women had both PP and PA. Also 70 women with PP had no bleeding and were not classified as having APH.
Record linkage
With the aid of a computer programme, LinkageWiz, probabilistic record linkage was used to match the ART data to the PDCU common identifying variables: name, date of birth and postcode (Tayor, 1998) . Once record linkage was complete, IVF clinical data were used to ensure matches to singleton births were correct. Cross-checking between the Victorian ART clinics was done to ensure the birth was not the result of ART at another clinic. Data were extracted for first singleton births within the study period of greater than 19 weeks gestation for the groups: IVF/ ICSI (6730), population control (24 619), GIFT (779) and non-ART (2167). Stillbirths, late terminations and neonatal deaths (within 28 days of birth) were included.
Data analysis
The background characteristics of the births in each of the four comparison groups were described using means and ranges for quantitative variables and percentages for categorical variables. The proportions of APH, PP, PA and PPH in each group were compared between the IVF/ ICSI group and each of the general population, GIFT and non-ART groups using the x 2 test. Logistic regression was performed using
GenStat 11th Edition (McCullagh and Nelder, 1989) to compare the odds of each complication between the IVF/ICSI and general population groups in unadjusted analyses and analyses adjusted for potential confounders: age, year of birth of baby, marital status, parity, previous miscarriage or termination of pregnancy, country of birth and vertex presentation (Model 1). Also giving birth in tertiary, private or other maternity hospitals was also included with the other factors in model (Model 2). For PPH, the effect of adjusting for other complications of pregnancy: pre-eclampsia, APH, PP, PA, premature rupture of membranes and induced labour, were added to Models 1 and 2. Also, because of the different definitions of post-partum haemorrhage for vaginal and Caesarean section deliveries, these were examined separately.
To determine which factors within the IVF/ICSI group were independently related to obstetric haemorrhages, causes of infertility, ovarian stimulation, fertilization procedure (IVF or ICSI), transfer of fresh or frozen embryos, number of embryos transferred, average embryo quality, average cell number, luteal phase support and number of fetal hearts were examined by logistic regression to adjust for the potential confounders listed above. Graphs were plotted to check the linearity and nature of the relationships between the data and the fit of the models. Additional analyses were performed omitting factors which might be an effect of the obstetric complication being studied, such as birth in a tertiary maternity hospital, to determine if these affected the relationship between the ART or infertility factor and the end-point. To study the possible effects of ovarian stimulation, oocyte numbers, fertilization rate and embryo numbers, and births resulting from fresh embryo transfer were analysed separately. Similarly, FET was analysed separately to examine factors specific to this group such as the effects of natural and artificial cycles and overnight culture of embryos after thawing.
Results
IVF/ICSI group compared with the control groups
The main differences in characteristics in the subjects in the groups are summarized in Table I . Compared with the IVF/ICSI group, the general population group were more likely to be born in Asia or the Middle East and migrated to Australia, to have previous pregnancies and to have a vertex presentation, and less likely to be married, give birth in a private hospital, have an induced labour or have an Caesarean section. Compared with the IVF/ICSI group, the GIFT patients were slightly younger, more often married, treated earlier in the study period and less likely to have Caesarean sections. The non-ART group were younger, more often born in Asia or the Middle East, more likely to have previous pregnancies, miscarriages and termination of pregnancy, and less likely to use a private hospital and have a Caesarean section than the IVF/ICSI group. The IVF/ICSI group had higher rates of all the haemorrhagic complications than the general population (Table II) . For GIFT, APH was more frequent than in the IVF/ ICSI group, whereas frequencies of PP and PA were similar and postpartum haemorrhage was less frequent than in the IVF/ICSI group. The non-ART group had frequencies of these complications intermediate between those in the general population and the IVF/ICSI group (Table II) .
The IVF/ICSI group had more of the obstetric haemorrhage complications than the general population group. The ORs changed little for APH, PP, PA and other APHs after the adjustments for confounders were made (Table III) . For post-partum haemorrhage, adjusting for covariates reduced the OR. The factors producing the greatest change in the OR were parity and Caesarean section. Analysing vaginal deliveries and Caesarean section births separately produced similar results. Thus there is some evidence for an additional effect of IVF/ICSI on post-partum haemorrhage independent of the increases in other maternal complications of pregnancy. The difference in the frequencies of the haemorrhages in Primiparous women in the IVF/ICSI group and in the general population group, by age, is shown in Fig. 1 .
Factors within the IVF/ICSI group affecting the risk of the haemorrhagic complications
Fresh versus frozen-thawed embryo transfers APH was more frequent with fresh embryo transfer than with FET (Tables IV and V) . Adjusting for other covariates made little difference to the OR for fresh embryo transfer versus FET. The weak evidence (P ¼ 0.1 -0.01) for effects of female infertility, tubal disease, three or more embryos transferred and luteal phase support with hCG was lost when fresh embryo transfer versus FET was included in the regression models. The data for PA were sparse (not shown) but there was moderately strong evidence (P ¼ 0.01) that PA was more frequent with fresh embryo transfer (49/ 1999 (1991-2004) 1999 (1991-2004) 1995 (1991-2004) 1997 (1991-2004) The number and (%) or mean and (range) is shown. *COB: country of birth; ME: middle East **Abortions include miscarriages and terminations of pregnancy before 20 weeks gestation.
(14/2503, 0.6%), OR 2.1 (1.2 -3.7), Model 2 adjusted OR 2.1 (1.2 -3.9). There was also some evidence that fresh transfers were associated with increased PP, but with less post-partum haemorrhage, indicating increased rates of post-partum haemorrhage with FET (Table IV) . The results for fresh embryo transfer in FSH stimulated cycles (fresh transfers in natural cycles excluded) and for FET in natural cycles (artificial cycles excluded) are compared in Table V . There were more APH and PA after fresh embryo transfer. There was also a trend to higher PP with the fresh transfers but no evidence of a difference in the frequency of post-partum haemorrhage with fresh embryo transfer or FET.
Number of oocytes collected before fresh embryo transfers
Analysing the results of fresh embryo transfer alone produced moderate evidence for an increase in frequency of APH with the number of 
Infertility diagnosis: endometriosis and ovulatory disorders
PP and post-partum haemorrhage were increased with endometriosis. Adding the other IVF/ICSI factors to the models did not change the OR greatly: PP 1.7 (1.2-2.4) and post-partum haemorrhage 1.3 (1.1 -1.6). Post-partum haemorrhage was also moderately strongly associated with ovulatory disorders and this continued after adding the other IVF/ICSI factors to the model [OR 1.3 (1.1-1.6)].
Hormone treatment
Post-partum haemorrhage was less frequent when hCG was used for luteal phase support. Adding the other IVF/ICSI covariates did not change the OR greatly [0.7 (0.6 -0.9)]. Analysing only the frozen embryo transfer results showed strong evidence (P , 0.001) for an increase in post-partum haemorrhage with FET in artificial cycles compared with natural cycles [OR 2.2 (95% CI 1.6-2.9), Adjusted OR 1.8 (1.3 -2.6)]. There were 93 postpartum haemorrhages following 458 FET in artificial cycles (20.3%) and 221 post-partum haemorrhages in 2045 FET in natural cycles (10.8%).
Factors within the IVF/ICSI group without strong evidence of an association with the haemorrhagic complications
Other factors analysed, including number of previous oocyte collections or ETs, types of ovarian stimulation and drugs used, source of sperm, overnight culture of embryos, maternal height, smoking and obesity (for which data were incomplete), showed no evidence of association with APH, PP or post-partum haemorrhage (P . 0.1).
Discussion
This large, multi-centre study shows increased rates of obstetric haemorrhage in mothers of singleton ART babies. Our results add to information in national and international studies (Dickey, 2007; Halliday, 2007; Anderson et al., 2008) . It has been hitherto uncertain whether the increases in these complications are caused by factors intrinsic to the ART procedures or factors related to the characteristics of the ART-seeking population. We have interrogated our data to address this question and examined possible mechanisms for these adverse outcomes.
The GIFT women were different because this group was small in number, younger, treated earlier and more often married than the IVF/ICSI group. They also had less Caesarean sections probably related to the increasing rate of Caesarean section over the time of the study. The GIFT method of treatment has become less popular over time with improvements in the results of IVF. Although they had less post-partum haemorrhage than the IVF/ICSI group, they had the same or higher rates of APH, PP and PA (Table II) . The significance of this is that in contrast to IVF and ICSI, embryos are not formed in vitro with GIFT. The oocytes and sperm are introduced into the outer end of the uterine tube and fertilization and early embryo cleavage occurs in vivo. GIFT was also usually used in couples with unexplained infertility. The fact that APH is not less frequent with GIFT than with IVF and ICSI indicates that it is not the fertilization and embryo manipulation within the laboratory that is responsible for the increased frequency of APH in the IVF/ICSI group. Furthermore, the adverse APH results with GIFT are also evidence that it is not the trans-cervical embryo transfer with low placement of embryos into the uterus that increases the risk of APH and particularly PP, as previously suggested (Smithers et al., 2003; Romundstad et al. 2006) . In contrast, as IVF/ICSI and GIFT are both undertaken during a stimulated cycle, factors common to both procedures such as ovarian stimulation, or anaesthesia and surgery for oocyte collection may be implicated in the adverse outcomes.
The non-ART group had fewer of the haemorrhages than the IVF/ ICSI group. From these data there is inconclusive evidence of increased rates of obstetric haemorrhages related to infertility; however, it is likely this group of patients had less severe infertility than did those in the IVF/ICSI group. It is possible but unlikely that some of these patients may have conceived by ART interstate or overseas. As this would bias this group's results towards more haemorrhages, we conclude there appears to be adverse effects of IVF/ICSI increasing the haemorrhagic complications separate from the infertility.
Having confirmed higher frequencies of APH and post-partum haemorrhage with ART, we were interested to determine if the differences in characteristics between subjects in the IVF/ICSI and general population groups would account for some or all of the effect. Although we matched the general population group and the IVF/ICSI subjects by age of mother and date of birth, this left some important differences between the two groups particularly in gravidity and parity. Also the IVF/ICSI group delivered by Caesarean section more often. Adjusting for confounding left the ORs for APH either unchanged or increased (Table III) . In contrast, for post-partum haemorrhage, the ORs decreased with adjustments for the other factors particularly parity, Caesarean section and other maternal complications (Table III) . Thus some of the higher frequency of post-partum haemorrhage after IVF/ICSI is explained by differences in the characteristics of women having these treatments from those in the general community, particularly their lower parity and higher use of Caesarean section. However, there remained some evidence of a small excess of post-partum haemorrhage related to some other aspect of IVF/ ICSI.
Having confirmed an increase in the obstetric haemorrhages specific to IVF/ICSI, we then analysed the IVF/ICSI group on its own to explore which factors were related to the higher frequencies of the haemorrhages. We found that APH, PP and PA were higher with fresh embryo transfer than with FET, and within the fresh embryo transfer treatments, APH increased with the numbers of oocytes collected. PP and post-partum haemorrhage were increased in subjects with endometriosis. Post-partum haemorrhage was also more frequent in women with ovulatory disorders, but less frequent when hCG had been used for luteal phase support. Post-partum haemorrhage was more frequent with FET treatments in artificial cycles than with FET in natural cycles. It is possible that some of these new findings may be statistically significant by chance alone and they need confirmation by analysis of separate datasets. Also it is difficult to know if these significant associations reflect direct mechanisms or result from a peripheral relationship. For example the luteal phase hCG and FET in artificial cycle effects maybe more related to the characteristics of the patients having these treatments than to the treatments themselves. However, if these findings are true there may be important implications and some speculation on the possible mechanisms, is useful for further studies.
There was a greater risk of APH after fresh embryo transfer in a stimulated cycle than FET in a natural cycle (Tables IV and V) . This increase in APH in general with fresh embryo transfer in stimulated cycles is particularly interesting. Differences in outcome of singleton births after fresh embryo transfer and FET have been noted for birthweight, preterm birth, perinatal death and some birth defects (Sutcliffe et al., 1995; Wennerholm et al., 1998; Aytoz et al., 1999; Kallen et al., 2005a; Olson et al., 2005; Belva et al., 2008; Shih et al., 2008) . These differences are intriguing, as they must result from either embryonic effects, with cryopreservation improving the outcomes by exerting some selective effect for better embryos, or adverse effects occurring in the mother in fresh embryo transfer cycles that are not present with FET. The latter may be related to ovarian stimulation and oocyte collection.
Anaesthesia or monitored conscious sedation for oocyte collection seems unlikely to explain the differences observed between stimulated and natural ART cycles. The initial half-life of anaesthetic medicines such as propofol is only 2-4 min: embryo transfer is typically 2-5 days after anaesthesia. Moreover, anaesthetic agents are not thought to act on the endometrium.
The increase in APH following fresh embryo transfer with the number of oocytes is a particularly important indicator that ovarian stimulation is involved. Oocyte number is related to the dose of FSH used and the ovarian responsiveness of the woman. Estradiol and progesterone levels at the time of implantation in fresh embryo transfer cycles would be expected to be associated with oocyte number. It may be that excessive ovarian hormone levels with multiple follicular developments interfere with the endometrium during implantation and increase the risk of APH and PA. We have recently shown that the endometrial protein, pregnancy associated plasma protein A (PAPP-A) is low in pregnancies after fresh embryo transfer in stimulated cycles (Amor et al., 2009) . PAPP-A is a zinc binding matrix metalloproteinase. PAPP-A helps regulate extracellular matrix remodelling. This is vital in angiogenesis and the establishment of placentation during the early weeks of pregnancy. Our finding of increased APH after fresh embryo transfer in stimulated ART cycles suggest that the high estradiol and progesterone concentrations, as a result of multiple folliculogenesis, produce suboptimal angiogenesis and placentation.
The diagnosis of endometriosis was associated with more PP and post-partum haemorrhage. Although PP was also associated with higher PPH, there was evidence that the effect of endometriosis increased the risk of both complications. We recently reported other potential obstetric consequences of endometriosis for ART: ovarian endometriosis is associated with approximately doubled rates of preterm birth and small for gestational age babies (Fernando et al., 2009) .
The less frequent post-partum haemorrhage with luteal phase hCG also suggests a disturbance of endometrial function around the time of implantation is involved in increasing PPH. In addition it suggests that improved management of luteal phase support in ART patients may have a beneficial effect. With FET there was more PPHs with the artificial cycles. This may be related directly to the hormone treatment being less effective in preparing the endometrium for implantation compared with natural cycles or, alternatively, the ovulatory disorder in the patients requiring artificial cycles may be responsible. Ovulatory disorders were also associated with increased post-partum haemorrhage.
The strengths of this study are the large study population and detailed information available on the treatments from the three infertility services and birth outcomes from the State PCDU database. The results of IVF/ICSI patients were compared with those of population controls, GIFT and non-ART conceptions in infertile women. Independent midwives, not ART clinic staff, recorded all obstetric data and this should minimize ascertainment bias. During the study period relatively low numbers of embryos were transferred, the multiple pregnancy rate was less that 20% and there were few 'vanishing twins'. The analysis of singleton births only and the high usage of FET is different from most other data for this time with higher multiple pregnancy rates. We could therefore study the influence of ovarian stimulation by comparing fresh embryo transfer with FET in a natural or non-stimulated cycle. We also assessed the effects of different methods of stimulation and a marker of the effect of stimulation: the number of oocytes collected before a fresh embryo transfer. To avoid the problem of analysis of subsequent pregnancies in the same woman and the high within subject correlations with repeated complications in subsequent pregnancies, for each woman only the first birth within the study period was analysed.
There are a number of limitations. The quality of the data is variable. For example, there were inevitable time-related changes over the 15 years of data collection, with differences in approach to diagnosis and procedures with the evolution of ART. There were not many women with PA. There was no information on covariates such as maternal weight or smoking during pregnancy in the general population group and this was also incomplete in the IVF/ICSI group. Another problem with these data is that we have no information of previous pregnancy complications particularly previous Caesarean section, which increases the risk of PP in subsequent pregnancies. We were not able to analyse these factors. Nevertheless, as 78% of the IVF/ICSI patients were primiparous (Table I) , we might have expected to see a higher rate of past Caesarean sections in the general population group thereby producing more PP cases: we observed the opposite. Thus it is not possible to treat the results as if they were from a clinical trial with random placement of couples in separate treatment groups or from a hypothesis based study, and conclusions on cause and effect need to be guarded.
In conclusion, all the obstetric haemorrhages are more frequent after IVF/ICSI than in the general population. For post-partum haemorrhage, some of the increase is related to the IVF/ICSI patients having fewer previous pregnancies and using Caesarean section more. As these complications are less frequent in non-ART conceptions in infertile women, the mechanism of the increase must involve some aspects of the IVF/ICSI treatment. As APH is not less frequent with GIFT, embryology procedures and embryo placement through the cervix do not appear to be important. Exploratory analysis of factors in the IVF/ICSI group suggests events around the time of implantation are responsible for the increase in subsequent obstetric haemorrhages. The increased APH with fresh embryo transfer and with greater numbers of oocytes collected, and the protective effect of hCG luteal phase support and the adverse effect of ovulatory disorders and artificial cycles for FET on PPH all indicate that suboptimal endometrial function around the time of implantation is critical.
